Biochemical aspects of schizophrenia.
D000662:Amphetamines / Q000009:adverse effects; D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007211:Indoles / Q000378:metabolism; D008636:Mesencephalon / Q000378:metabolism; D008715:Methionine / Q000494:pharmacology; D008745:Methylation; D008995:Monoamine Oxidase / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000378:metabolism; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism; D012559:Schizophrenia / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism*
D000662:Amphetamines; D014150:Antipsychotic Agents; D002395:Catecholamines; D007211:Indoles; D011954:Receptors, Dopamine; D008715:Methionine; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine